Shared and unique genetic contributions to attention deficit/hyperactivity disorder and substance use disorders: A pilot study of six candidate genes
SourceEuropean Neuropsychopharmacology, 23, 6, (2013), pp. 448-57
Article / Letter to editor
Display more detailsDisplay less details
PI Group MR Techniques in Brain Function
Primary and Community Care
PI Group Memory & Emotion
F.C. Donders Centre for Cognitive Neuroimaging
Epidemiology, Biostatistics & HTA
Subject150 000 MR Techniques in Brain Function; DCN MP - Plasticity and memory; DCN PAC - Perception action and control; DCN PAC - Perception action and control IGMD 3: Genomic disorders and inherited multi-system disorders; DCN PAC - Perception action and control NCEBP 9 - Mental health; IGMD 3: Genomic disorders and inherited multi-system disorders DCN MP - Plasticity and memory; NCEBP 1: Molecular epidemiology ONCOL 5: Aetiology, screening and detection; NCEBP 7: Effective primary care and public health; NCEBP 9: Mental health; ONCOL 5: Aetiology, screening and detection; ONCOL 5: Aetiology, screening and detection
The shared genetic basis of attention deficit/hyperactivity disorder (ADHD) and substance use disorders (SUDs) was explored by investigating the association of candidate risk factors in neurotransmitter genes with both disorders. One hundred seven methadone maintenance treatment patients, 36 having an ADHD diagnosis, 176 adult patients with ADHD without SUDs, and 500 healthy controls were genotyped for variants in the DRD4 (exon 3 VNTR), DRD5 (upstream VNTR), HTR1B (rs6296), DBH (rs2519152), COMT (rs4680; Val158Met), and OPRM1 (rs1799971; 118A>G) genes. Association with disease was tested using logistic regression models. This pilot study was adequately powered to detect larger genetic effects (OR>/=2) of risk alleles with a low frequency. Compared to controls, ADHD patients (with and without SUDs) showed significantly increased frequency of the DBH (rs2519152: OR 1.73; CI 1.15-2.59; P=0.008) and the OPRM1 risk genotypes (rs1799971: OR 1.71; CI 1.17-2.50; P=0.006). The DBH risk genotype was associated with ADHD diagnosis, with the association strongest in the pure ADHD group. The OPRM1 risk genotype increased the risk for the combined ADHD and SUD phenotype. The present study strengthens the evidence for a shared genetic basis for ADHD and addiction. The association of OPRM1 with the ADHD and SUD combination could help to explain the contradictory results of previous studies. The power limitations of the study restrict the significance of these findings: replication in larger samples is warranted.
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.